AT
alexia tsakaneli
United Kingdom
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Harnessing Chemotherapy Resistance and development of Novel Therapeutic strategies for Acute Leukemia with KMT2A (MLL)-gene rearrangements
Harnessing Chemotherapy Resistance and development of Novel Therapeutic strategies for Acute Leukemia with KMT2A (MLL)-gene rearrangements
7,882
Total downloads
29k
Total views and downloads
56 Authors
- AD
ambra da ros
Pediatric Haematology-Oncology and Hematopoietic Cell and Gene Therapy Division
Italy
- AB
angelika bongers
Children’s Cancer Institute, Lowy Cancer Research Institute, University of New South Wales
Australia
- AH
anna hagström-andersson
Division of Clinical Genetics
Sweden
- AM
anna mariana
Children’s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales (UNSW) Sydney
Australia
- AC
aurélie caye-eude
Département de Génétique, UF de Génétique moléculaire
France
- BB
belamy b. cheung
Children’s Cancer Institute, Lowy Cancer Research Institute, University of New South Wales
Australia
- BA
bruno a. lopes
Acute Leukemia RioSearch Group
Brazil
- CP
caroline pires poubel
Acute Leukemia RioSearch Group
Brazil
- CT
claudia tregnago
Pediatric Haematology-Oncology and Hematopoietic Cell and Gene Therapy Division
Italy
- CE
cristiane esteves teixeira
Bioinformatics and Computational Biology Laboratory
Brazil
- GL
giorgia longo
Pediatric Haematology-Oncology and Hematopoietic Cell and Gene Therapy Division
Italy
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore